semaglutide inflammation reddit The NLRP3 inhibitor NT‐0796 enhances and sustains GLP‐1R agonist‐mediated weight loss in a murine diet‐induced obesity model - Thornton - 2025 - Obesity Semaglutide and NT-proBNP in Obesity-Related

Adults who have at least one weight-related medical issue and are deemed overweight may also be eligible

Tolerability and Safety Common side effects were primarily gastrointestinal and occurred mainly during dose escalation phases

Although this potential benefit is not fully proven, ongoing studies are exploring how semaglutide may impact inflammatory processes

Starting dose - If you've had no side effects and your gap between doses is less than 3 weeks, you may be eligible to start as advised by your clinician

Many users have taken to various platforms to share their experiences, and the feedback can be quite revealing

DOI: 10.1159/000050367 44